USPSTF: Ovarian cancer screen to be avoided for most women

July 20, 2017

(HealthDay)—The potential harms of ovarian cancer screening outweigh the benefits, so only very specific groups of women should be screened for the disease, the U.S. Preventive Services Task Force (USPSTF) says in a draft recommendation.

The new guidance reaffirms a 2012 final recommendation made by the Task Force. The USPSTF noted that no other major medical organization recommends screening for ovarian cancer among women in the general population.

"The found that screening women without signs or symptoms for ovarian cancer does not decrease the number of deaths from the disease, and may lead to ," Task Force member Maureen Phipps, M.D., M.P.H., said in a USPSTF news release. "Therefore, the Task Force recommends against screening for ovarian cancer in women who have no signs or symptoms, and who are not at high risk for ."

The draft recommendation statement and draft evidence review are posted for public comment on the Task Force website. Comments can be submitted from July 18 through Aug. 14.

Explore further: Hormone therapy not advised for preventing disease after menopause

More information: Evidence Review
Draft Recommendation Statement
Comment on Recommendation Statement

Related Stories

Hormone therapy not advised for preventing disease after menopause

May 17, 2017
(HealthDay)—Using hormone therapy to prevent chronic health issues, such as heart disease and bone loss, in postmenopausal women may do more harm than good, the U.S. Preventive Services Task Force (USPSTF) says.

USPSTF: evidence lacking for pelvic screening examinations

June 29, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to weigh the balance of benefits and harms for screening pelvic examinations in asymptomatic, nonpregnant ...

USPSTF recommends CRC screening for 50- to 75-year-olds

October 6, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation ...

USPSTF: Not enough evidence to screen for OSA in asymptomatic

January 26, 2017
(HealthDay)—Current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea (OSA) in adults without any known signs or symptoms of the condition, according to a U.S. ...

USPSTF recommends BP screening for preeclampsia

September 28, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) concludes that there is a net benefit for preeclampsia screening with blood pressure measurements throughout pregnancy (B recommendation). These findings form ...

USPSTF finds evidence lacking for sleep apnea screening

June 15, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found insufficient evidence for the benefit of obstructive sleep apnea (OSA) screening in asymptomatic populations. These findings form the basis of a draft ...

Recommended for you

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

October 22, 2018
Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RNA called metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to suppress breast cancer metastasis in mice, ...

Revealing the molecular mystery of human liver cells

October 22, 2018
A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular ...

Targeting a hunger hormone to treat obesity

October 22, 2018
About 64 per cent of Canadian adults are overweight or obese, according to Health Canada. That's a problem, because obesity promotes the emergence of chronic diseases such as type 2 diabetes, heart disease and some cancers.

New tool gives deeper understanding of glioblastoma

October 22, 2018
Researchers in the lab of Charles Danko at the Baker Institute for Animal Health have developed a new tool to study genetic "switches" active in glioblastoma tumors that drive growth of the cancer. In a new paper in Nature ...

Pancreatic cancer genetic marker may predict outcomes with radiation therapy

October 22, 2018
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center—Jefferson Health and Lankenau Institute for Medical Research scientists find ...

New drug combination destroys chemo-resistant blood cancer

October 22, 2018
Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.